These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11794097)

  • 1. [Peculiarities of the occurrence of soft tissue disorders and prospects of their closure in patients with diabetes mellitus].
    Driuk MF; Podpriatov SIe; Lisovets' VV; Rohachova VP
    Klin Khir; 2001 Aug; (8):14-6. PubMed ID: 11794097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of prostaglandin E1 and systemic antibacterial therapy application in patients with diabetes mellitus and purulent-necrotic lesions of the foot].
    Podpriatov SIe; Hrabovyĭ OM; Salata VV; Zaĭtsev SV; Simonova ZIe; Korbut SM; Shyshova SIa; Rohacheva VP
    Klin Khir; 2010; (11-12):76-8. PubMed ID: 21268804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of vascular therapy in complex of treatment of purulent necrotic foot ulcers in patients with diabetes mellitus].
    Podpriatov SIe; Lisovets' VV; Huch AO; Tovkun VK; Slobodeniuk IM; Hupalo IuM
    Klin Khir; 2001 Feb; (2):27-9. PubMed ID: 11482020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial therapy of purulent necrotic foot lesions in patients with diabetes mellitus].
    Podpriatov SIe; Larionov HM; Simonova ZIe; Tovkun VK
    Klin Khir; 2001 Aug; (8):42-7. PubMed ID: 11794111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-radiological estimation of the foot changes in patients with diabetes mellitus].
    Petrovs'kyĭ MM; Kharchevnaia AF; Podpriatov SIe; Il'kin OV; Zubariev VG
    Klin Khir; 2001 Aug; (8):37-9. PubMed ID: 11794109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary syndrome in patients with diabetic foot].
    Mazurok LM
    Klin Khir; 2001 Aug; (8):32-3. PubMed ID: 11794106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of purulent and necrotic lesions of the lower extremities in patients with diabetes mellitus].
    Ohonovsky? VK; Podil?hak MD; Matskiv AS; Kravets SL; Tsemekhin BD
    Klin Khir (1962); 1993; (9-10):37-40. PubMed ID: 8158919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of diabetic foot infections.
    Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
    Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vast purulent necrotic lesions in patients with diabetes mellitus].
    Liul'ko IB; Kosul'nikov SO; Tarnopolskiĭ SA
    Klin Khir; 2001 Aug; (8):28-30. PubMed ID: 11794104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vision in patients with the diabetic foot during the treatment with alprostan].
    Veselovskaia NN
    Klin Khir; 2001 Aug; (8):61-2. PubMed ID: 11794121
    [No Abstract]   [Full Text] [Related]  

  • 11. [Causes of unsatisfactory outcome in patients with diabetes mellitus complicated by necrotic inflammation of the foot].
    Fedorenko VP
    Klin Khir; 1999; (3):16-9. PubMed ID: 10370287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical treatment of purulent necrotic complications in patients with diabetic foot syndrome].
    Datsenko BM; Belov SG; Girka EI
    Klin Khir; 2001 Aug; (8):10-2. PubMed ID: 11794095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selective intraarterial application of Thienam and Vasoprostan in the treatment of purulent foot diseases in patients with diabetes mellitus].
    Antsypovich EA; Molchanov VF; Kadyshev IuG; Brusnitsyna MA
    Klin Khir; 1998; (8):53. PubMed ID: 9866335
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conservative therapy of tissue decubitus in a combined therapy of patients with obliterating disease and diabetes-related vascular injuries].
    Michalov VG; Seliuk VM; Cherniak VA; Osadchiĭ AI; Litvinova NIu
    Klin Khir; 2002; (11-12):47-8. PubMed ID: 12549284
    [No Abstract]   [Full Text] [Related]  

  • 15. [Calcitonin in treatment of diabetic foot syndrome].
    Zmijewska M; Imiela J; Ciszek M
    Pol Tyg Lek; 1994 Jan 3-17; 49(1-3):23-5. PubMed ID: 8008672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of alprostan in combination with "Bioptron-II" rays and iruxol-miramistin in the treatment of the diabetic foot complicated by atherosclerosis].
    Tomashuk IP; Tomashuk II
    Klin Khir; 2001 Aug; (8):49-51. PubMed ID: 11794113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of prostaglandin E1 and Naftidrofuryl in combined treatment of purulent-necrotic complications of the diabetic foot syndrome].
    Girka EI; Bazarinskaia ZI; Kravtsov EA
    Klin Khir; 2002; (11-12):21-2. PubMed ID: 12549263
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
    Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
    J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of multiple risk factors affecting the result of free flap transfer for necrotising soft tissue defects of the lower extremities in patients with type 2 diabetes mellitus.
    Lee YK; Park KY; Koo YT; Baek RM; Heo CY; Eun SC; Lee TS; Lee KM; Kim BK
    J Plast Reconstr Aesthet Surg; 2014 May; 67(5):624-8. PubMed ID: 24581954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peculiarities of surgical treatment of patients with complicated forms of the diabetic foot syndrome].
    Antoniuk SM; Sviridov NV; Popandopulo AG; Akhrameev VB; Golovnia PF; Lomako AI
    Klin Khir; 2005 Oct; (10):36-9. PubMed ID: 16509083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.